Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04494776Recruiting

SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study

Role: lead

NCT01895049Phase 4Completed

Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

Role: lead

NCT01833416Completed

Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients

Role: lead

NCT01802268Phase 4Completed

Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

Role: lead

All 4 trials loaded